Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 13;6(17):4989-4993.
doi: 10.1182/bloodadvances.2021006468.

Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML

Geoffrey L Uy  1 , Laura F Newell  2 , Tara L Lin  3 , Stuart L Goldberg  4 , Matthew J Wieduwilt  5 , Robert J Ryan  6 , Stefan Faderl  7 , Jeffrey E Lancet  8
Affiliations

Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML

Geoffrey L Uy et al. Blood Adv. .

Erratum in

No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Post-alloHCT Outcomes. (A) OS landmarked from the alloHCT date. Reprinted from Lancet Hematology with permission from Elsevier. (B) Subgroup analyses of OS landmarked from the alloHCT date. “N” denotes the number of patients who proceeded to alloHCT. One patient who achieved a best response of CR relapsed before alloHCT. (C) Cumulative incidence of relapse. (D) Cumulative incidence of NRM. CMML, chronic myelomonocytic leukemia; HMA, hypomethylating agent.
See this image and copyright information in PMC

References

    1. Tardi P, Johnstone S, Harasym N, et al. . In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. Leuk Res. 2009;33(1):129-139. - PubMed
    1. Jazz Pharmaceuticals. VYXEOS® (daunorubicin and cytarabine) Liposome for Injection, for Intravenous Use [Package Insert]. Palo Alto, CA: Jazz Pharmaceuticals; 2021.
    1. European Medicines Agency. Vyxeos liposomal 44 mg/100 mg powder for concentrate for solution for infusion. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/vyxeos-liposomal. Accessed 14 October 2021.
    1. Lancet JE, Uy GL, Cortes JE, et al. . CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J Clin Oncol. 2018;36(26):2684-2692. - PMC - PubMed
    1. Cornelissen JJ, van Putten WL, Verdonck LF, et al. . Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood. 2007;109(9):3658-3666. - PubMed

Publication types